TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Vaccinia Sverige AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
918
|
731
|
585 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
159
|
95
|
2 |
| EBITDA |
156
|
97
|
5 |
| Total assets |
368
|
272
|
189 |
| Current assets |
367
|
268
|
183 |
| Current liabilities |
48
|
47
|
31 |
| Equity capital |
300
|
207
|
144 |
| - share capital |
5
|
4
|
5 |
| Employees (average) |
4
|
4
|
3 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
81.5%
|
76.1%
|
76.2% |
| Turnover per employee |
230
|
183
|
195 |
| Profit as a percentage of turnover |
17.3%
|
13.0%
|
0.3% |
| Return on assets (ROA) |
43.2%
|
34.9%
|
1.1% |
| Current ratio |
764.6%
|
570.2%
|
590.3% |
| Return on equity (ROE) |
53.0%
|
45.9%
|
1.4% |
| Change turnover |
185
|
193
|
-236 |
| Change turnover % |
25%
|
36%
|
-29% |
| Chg. No. of employees |
0
|
1
|
0 |
| Chg. No. of employees % |
0%
|
33%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.